New report finds that Trikafta patients’ admissions to hospital fell by an average of 65 per cent over one year – but at a ...

More cystic fibrosis (CF) patients in Saskatchewan now have access to Trikafta, a groundbreaking medication that improves ...

Rena Barrow has two sons with cystic fibrosis, born 20 years apart — but they faced the same terrible delay in diagnosis.

Cystic fibrosis has traditionally been considered a fatal disease. But thanks to medical advancements and treatments, many ...

The provincial government announced Monday that more cystic fibrosis (CF) patients in Saskatchewan are now eligible for ...

"There is a grey cloud there, but there are ways of managing that grey cloud, there are ways to plan for it and there are ...

Lauren Butler, inspired by her daughter’s battle with cystic fibrosis, takes on the London Marathon to raise funds and ...

Enterprise Therapeutics Ltd (Enterprise), a biopharmaceutical company dedicated to the discovery and development of novel therapies to improve the lives of people with respiratory diseases, today ...

There are already cystic fibrosis drugs on the market: Vertex has developed a range of drugs that for the first time address the malfunctioning protein that is the cause of the disease.

NHS England has agreed a deal with Vertex for its three-drug cystic fibrosis therapy Kaftrio, just days after the EMA’s human medicines committee recommended approval of the drug. The deal means ...

Dr. Albritton is a resident physician and Dr. Kingdom is Assistant Professor in the Department of Otolaryngology at Emory University School of Medicine, Atlanta, Ga. Albritton FD, Kingdom TT.